The Li research group in the Department of Biomedical Engineering at the University of Michigan, Ann Arbor focuses on the development of molecular and live cell-based therapeutics, with a major emphasis on the use of bioconjugation chemistry, synthetic biology, and microbiology to interrogate and manipulate interactions between therapeutics, the microbiome, and host.